ARCHIVES

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

Older Patients Can Do Well With Stem Cell Transplants

March 30, 2007

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977